What's new

This blog highlights one of the first studies identifying and characterizing the novel coronavirus, ultimately contributing to the viral genome sequence being shared worldwide.

07/29/2020

Learn why Takara Bio was awarded "Best Customer Service" two years in a row.

07/20/2020

Dr. Windi Muziasari, CEO of Resistomap, talks about how they are fighting the spread of antibiotic resistance genes by providing robust tools for monitoring.

06/23/2020

Find out which types of SARS-CoV-2 vaccines are out there and how Takara Bio is joining the fight.

06/19/2020

Technology spotlight

Clone any insert, with any vector, at any site. In-Fusion seamless cloning technology makes it easy! Here’s how.

Constant genetic variation is the norm for influenza. Learn how a clever team of researchers overcame this challenge using In-Fusion Cloning for accurate, fast, and standardized subcloning—cutting the time from outbreak to vaccine: That's Good Science!